Related Experiment Video

Updated: Jun 5, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

Published on: March 7, 2017

Therapeutic implications of GIPC1 silencing in cancer

Thomas W Chittenden1, Jane Pak, Renee Rubio

  • 1Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America.

Plos One
|January 7, 2011
PubMed

Insights

GIPC1 (GIPC member 1) protein is highly expressed in cancers and promotes tumor growth. Inhibiting GIPC1 can stop cancer cell survival and growth, suggesting it as a new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • GIPC1 (GIPC member 1) is a cytoplasmic scaffold protein involved in receptor signaling.
  • High GIPC1 expression is observed in various human cancers, including breast, ovarian, gastric, and pancreatic cancers.
  • Previous studies suggest GIPC1's role in tumorigenesis.

Purpose of the Study:

  • To investigate the role of GIPC1 in oncogenic transformation and cancer cell survival.
  • To explore GIPC1 as a potential therapeutic target for cancer treatment.

Main Methods:

  • GIPC1 expression was suppressed in human breast, colorectal cancer cell lines, and human mammary epithelial cells (HMECs).
  • Gene expression and cellular phenotypes were analyzed.
  • A GIPC1 knock-down gene signature was used to analyze public microarray datasets of breast and ovarian cancers.

Main Results:

  • GIPC1 suppression promoted apoptosis in multiple cancer cell lines (MCF-7, MDA-MD231, SKBR-3, SW480, SW620).
  • GIPC1 suppression impaired anchorage-independent colony formation in HMECs.
  • The GIPC1 signature correlated with breast and ovarian cancer phenotypes, clinical outcomes, and patient survival.

Conclusions:

  • GIPC1 plays a critical role in oncogenic transformation and is essential for the survival of breast and colorectal cancer cells.
  • GIPC1 inhibition represents a promising therapeutic strategy for human cancers.
  • GIPC1 expression levels can serve as a prognostic biomarker in breast and ovarian cancers.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...